What is the CVR number of Breye Therapeutics ApS?

Breye Therapeutics ApS is registered with CVR / Virk under CVR 40279865.

What is the revenue of Breye Therapeutics ApS?

Breye Therapeutics ApS reported revenue of DKK -7,5M in 2025.

Breye Therapeutics ApS employs 4 people as of the latest annual report.

Ulrik Mouritzen is the CEO of Breye Therapeutics ApS.

Jimmy Arnold V Van Heusden chairs the board of Breye Therapeutics ApS, in role since 2022.

Breye Therapeutics ApS's registered address is Agern Alle 24.

APSActiveAdvertising protection

CVR 40279865Agern Alle 24, 2970 HørsholmManufacture of pharmaceutical preparations· NACE 2120Est. 2019 · 7 years old4 employees

Actively employed in the business

Name	Role	Member since
Current (1)
UM Ulrik Mouritzen Chief Executive Officer	Chief Executive Officer	2019

Non-executive oversight

Name	Role	Member since
Current (5)
JS Jørgen Søberg Petersen Board of Directors	Board of Directors	2022
GB Gabriela Burian Board of Directors	Board of Directors	2022
CR Chiara Rossana Maria Liberati Board of Directors	Board of Directors	2023
JA Jimmy Arnold V Van Heusden Chairman	Chairman	2022
CJ Carl Johan Kördel Board of Directors	Board of Directors	2022

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Novo Holdings A/S	Company	33.33–49.99%	33.33–49.99%	2024
Sound Bioventures Fund I AB	Individual	20–24.99%	20–24.99%	2023
Visus Holding ApS	Company	10–14.99%	10–14.99%	2024
BII Holdings A/S	Company	5–9.99%	5–9.99%	2023
Golgi NueroSciences S.R.L.	Individual	5–9.99%	5–9.99%	2024
Bradford A. Young	Individual	5–9.99%	5–9.99%	2020
BioInnovation Institute Fonden	Company	10–14.99%	10–14.99%	2022

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.